Oncology Support Oncology Support

This category contains active cancer treatments, not general supportive-care products. Treatment choice, dose and monitoring are determined by an oncology team.

Nolvadex

Tamoxifen

10 · 20mg

Formulated to manage hormone-receptor-positive breast cancer and to support treatment outcomes through oestrogen receptor inhibition.

From $0.32 / tablet View

Arimidex

Anastrozole

1mg

Arimidex is developed to target hormone-dependent breast cancer and is formulated to alleviate tumour progression.

From $2.34 / tablet View

Armotraz

Anastrozole

1mg

Indicated to help manage oestrogen-dependent conditions by supporting the suppression of excess hormone production in postmenopausal patients.

From $3.11 / tablet View

Femara

Letrozole

2.5mg

Femara is indicated for the treatment of hormone-dependent breast cancer and utilized to alleviate tumour growth in post-menopausal women.

From $0.51 / tablet View

Casodex

Bicalutamide

50mg

Designed to target tumour growth, indicated to manage advanced prostate cancer effectively.

From $5.32 / tablet View

Methotrexate Tablets

Methotrexate

2.5mg

Utilized to manage autoimmune responses and indicated to alleviate inflammation-related tissue damage effectively.

From $0.73 / tablet View

Leukeran

Chlorambucil

2 · 5mg

Utilized to manage specific types of blood cancers, formulated to slow the progression of malignant cellular growth in the lymphatic system.

From $3.12 / tablet View

Cytoxan

Cyclophosphamide

50mg

Utilized to target malignant neoplasms to alleviate disease progression and cell proliferation.

From $2.63 / tablet View

Hydrea

Hydroxycarbamide

500mg

Developed to alleviate conditions involving abnormal blood cell growth to address long-term stability and symptom control.

From $2.17 / tablet View

Alkacel

Melphalan

2mg

Formulated to address malignant cell proliferation by supporting the alkylation of DNA and inhibiting cellular replication.

From $5.52 / tablet View

Capnat

Capecitabine

500mg

Developed to target cancerous growths by utilizing systemic conversion to therapeutic agents that inhibit DNA synthesis.

From $2.98 / tablet View

Efudex

Fluorouracil

1 · 5%

Utilized to target actinic keratosis and intended to support the reduction of cancerous skin cell proliferation.

From $8.67 / tube View

Tasigna

Nilotinib

150 · 200mg

Utilized to target specific protein kinases in chronic myeloid leukaemia and designed to alleviate disease progression in affected patients.

From $12.75 / tablet View

Sprycel

Dasatinib

50mg

Utilized to target kinase-positive leukaemias and formulated to support the mitigation of malignant cell growth in patients.

From $144.50 / bottle View

Abiraterone Tablets

Abiraterone

250mg

Developed to target prostate cancer progression, this medication is utilized to alleviate hormonal signals that support tumour growth.

From $3.15 / tablet View

Aromasin

Exemestane

25mg

Developed to target oestrogen production and indicated to support cancer treatment, this inhibitor is utilized to address hormone-sensitive malignancies.

From $4.73 / tablet View

Thalix

Thalidomide

50 · 100mg

Formulated to alleviate symptoms of multiple myeloma to support patient stabilization.

From $1.73 / capsule View

Nexavar

Sorafenib

200mg

Developed to address carcinoma growth to alleviate tumour progression.

From $5.87 / tablet View

Gleevec

Imatinib

100 · 400mg

Designed to target cancer cells to alleviate disease progression.

From $3.89 / tablet View

Afinitor

Everolimus

5 · 10mg

Developed to target cancer cells to support tumour growth suppression.

From $34.00 / tablet View

Eulexin

Flutamide

250mg

Formulated to target prostate cancer to alleviate hormonal progression.

From $2.02 / tablet View

Key takeaways

  • Hormonal therapies act on hormone-sensitive cancers; chemotherapy medicines work through different cancer-specific mechanisms.
  • Medicines in this category are not interchangeable and may be used alone or as part of a wider regimen.
  • Blood tests and other monitoring are often needed to manage infection, bleeding, clotting and organ-related risks.

Listings are for comparison only; suitability and supply depend on the treating clinician, specialist prescription and pharmacy checks.

How the medicine groups differ

Hormonal therapies include anastrozole, tamoxifen and flutamide. Chemotherapy or cytotoxic medicines include cyclophosphamide, chlorambucil and hydroxycarbamide. Their uses and risk profiles differ substantially.

What these medicines are used for

Depending on the medicine and regimen, uses may include breast cancer, prostate cancer, multiple myeloma and chronic myeloid leukaemia.

Important safety checks

Do not start, stop, substitute or change a cancer medicine without the oncology team. Monitoring may include blood counts and liver, kidney, heart or hormone-related checks. Pregnancy prevention, vaccination plans and interactions with other medicines or supplements may also need specialist review.

When to seek urgent care

Follow the oncology team’s emergency instructions. Seek urgent help for fever or signs of infection, unusual bleeding, sudden breathlessness, chest pain, one-sided leg swelling, severe vomiting or diarrhoea, confusion, or a serious allergic reaction.